
News
Merck Animal Health consolidates small
animal vaccines under one global brand
- Nobivac® Lyme, the first and only Lyme vaccine shown to elicit OspA and OspC borelliacidal activity1.
- Nobivac® FeLV, the first and only FeLV vaccine with a 2-year Duration of Immunity for flexible feline
vaccination protocols.
- Nobivac® Lepto4, the first and only vaccine labeled to aid in the prevention of leptospirosis and mortality caused by the
4 key Leptospira serovars.*
1. LaFleur RL, Dant JC, Wasmoen TL, et al. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol. 2009;16:253–259.
*L. canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona.